Dna encoding a mammalian receptor (fb41a) and uses thereof
CA 2354685 A1 · Owner: Bard, Jonathan A. · Inventors: Bard, Jonathan A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides an isolated nucleic acid encoding a mammalian fb41a receptor, a purified mammalian fb41a receptor vectors comprising isolated , nucleic acid encoding a mammalian fb41a receptor cells comprising such , vectors, antibodies directed to a mammalian fb41a receptor nucleic acid , probes useful for detecting nucleic acid encoding a mammalian fb41a receptor antisense oligonucleotides complementary to unique sequences of nucleic acid encoding a mammalian fb41a receptor, transgenic nonhuman animals which , express DNA encoding a normal or mutant mammalian fb41a receptor methods of , isolating a mammalian fb41a receptor methods of treating an abnormality that is linked to …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 10, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 10, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 10, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.